21:25 3 October 2025
Celon Pharma commissions construction of factory in Slovakia for PLN 63.3 mln
Celon Pharma Slovakia, a subsidiary of Celon Pharma, has signed a contract worth PLN 63.3 million with Polonez Plus for the construction of a production facility in the Žilina business park, Slovakia. The plant will provide manufacturing capacity for GLP-1 analog-based therapies and diversify the company’s production geographically. The contractor will handle procurement, supply of equipment and materials, preparatory works, and later full construction once a building permit is secured.
Completion is expected within 12 months from the start. The project marks a key step in Celon Pharma’s strategy to expand modern therapy development and production infrastructure.
Celon Pharma has been listed on Warsaw’s main market since 2016.
